Company profile for Restem

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RESTEM Group is a clinical-stage biotechnology company focused on pioneering adult stem cell therapies. With one Phase 2/3 and one Phase 1 clinical trial currently underway, and another Phase 2 trial set to begin, RESTEM has successfully completed three Phase 1 trials. Through its proprietary Restem-L platform, which utilizes Umbilical Lining Stem Cells (ULSC), RESTEM aims to develop best-in-class treatments for the underserve...
RESTEM Group is a clinical-stage biotechnology company focused on pioneering adult stem cell therapies. With one Phase 2/3 and one Phase 1 clinical trial currently underway, and another Phase 2 trial set to begin, RESTEM has successfully completed three Phase 1 trials. Through its proprietary Restem-L platform, which utilizes Umbilical Lining Stem Cells (ULSC), RESTEM aims to develop best-in-class treatments for the underserved autoimmune community.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1728 Coral Way Suite 500 Miami, FL 33145
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/11/3148766/0/en/RESTEM-to-Host-R-D-Day-Highlighting-its-Next-Generation-Immunomodulatory-Treatment-for-Autoimmune-and-Inflammatory-Diseases.html

GLOBENEWSWIRE
11 Sep 2025

https://www.globenewswire.com/news-release/2025/06/06/3095442/0/en/RESTEM-to-Present-Phase-2-3-IIMPACT-Trial-Design-in-Idiopathic-Inflammatory-Myopathy-at-EULAR-2025-Congress.html

GLOBENEWSWIRE
06 Jun 2025

https://www.globenewswire.com/news-release/2025/06/03/3093055/0/en/RESTEM-to-Present-at-the-2025-BIO-International-Convention.html

GLOBENEWSWIRE
03 Jun 2025

https://www.globenewswire.com/news-release/2025/04/01/3053284/0/en/RESTEM-to-Participate-in-Jones-Las-Vegas-Technology-and-Innovation-Conference.html

GLOBENEWSWIRE
01 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty